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Abstract
Blood-based bioenergetic profiling has promising applications as a minimally invasive biomarker 
of systemic bioenergetic capacity. In this study, we examined peripheral blood mononuclear cell 
(PBMC) mitochondrial function and brain morphology in a cohort of African Americans with 
longstanding Type 2 diabetes. Key parameters of PBMC respiration were correlated with white 
matter, gray matter, and total intracranial volumes. Our analyses indicate that these relationships 
are primarily driven by the relationship of systemic bioenergetic capacity with total intracranial 
volume, suggesting that systemic differences in mitochondrial function may play a role in overall 
brain morphology.
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Introduction
Type 2 diabetes mellitus (T2DM) is one of the most common diseases in older adults (1). 
Those with T2DM are susceptible to diseases like neuropathy, retinopathy, nephropathy, 
stroke, and ischemic heart disease, and are more likely to suffer from cognitive impairment 
and experience a higher risk of dementia (2–4), cerebral infarctions and loss of total gray 
matter, white matter, and hippocampal volumes (5, 6).
Studies of brain tissues and neurons show that mitochondrial bioenergetics regulate brain 
energy homeostasis and metabolism during development (7), and affect brain function and 
cognition (8). Indeed, the brain has an exceptionally high metabolic demand rendering it 
highly sensitive to changes in systemic bioenergetic capacity (9, 10). There is growing 
evidence linking central and peripheral metabolic alterations in the pathophysiology of 
neurodegenerative diseases. Such relationships may be due to intercellular signaling 
mediated by non-cellular, blood-borne circulating factors such as inflammatory cytokines, 
redox stress, mitokines, and exosomes (11–15). These factors can have systemic effects on 
the bioenergetic capacity across multiple organs, as well as circulating cells that are 
continuously exposed to them. Previous publications from our group support this premise 
and provide direct evidence that the assessment of mitochondrial function in circulating cells 
is associated with the bioenergetic capacity of different highly metabolically active organs 
such as the brain, heart, and skeletal muscle (23, 24). To date, the bioenergetic profiles of 
peripheral blood mononuclear cells (PBMCs) and platelets have been associated with several 
age-related disorders, including diabetes, atherosclerosis, and neurodegeneration (16–22).
This study aimed to examine the relationships between the bioenergetic capacity of PBMCs 
and key features of brain morphology: total gray matter volume (TGM), total white matter 
volume (TWM), total intracranial volume (TICV). We focused on African American 
individuals with T2DM who participated in African American-Diabetes Heart Study MIND 
(AA-DHS MIND). African Americans have a higher risk of T2DM (25), leading to an 
increased risk for cognitive impairment (26, 27). We tested the hypothesis that PBMC 
bioenergetics capacity correlates with brain structure and cognitive performance by 
examining the relationships between PBMC respiration and total and regional brain volumes 
measured by MRI and Montreal Cognitive Assessment (MoCA) scores. To our knowledge, 
this is the first study to specifically examine these relationships in an African American 
population.
Experimental Methods
Participants
AA-DHS MIND is a cross-sectional genetic and epidemiologic study designed to evaluate 
and improve the understanding of risk factors for impaired cognitive performance and to 
assess cerebral architecture using magnetic resonance imaging (MRI) in African Americans 
with T2D. It builds on the AA-DHS study, which is an extension of the Diabetes Heart 
Study (DHS) (28) designed to assess the relationship between cognitive impairment and 
cerebrovascular disease in an African American cohort. The study was approved by the 
Wake Forest School of Medicine (WFSM) Institutional Review Board and all participants 
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provided written, informed consent. We recruited 16 unrelated African Americans. 
Participants (9 women and 7 men) were older (51.7–81.8 years), overweight or obese (body 
mass index [BMI] > 25.5–50.6 kg/m2), and sedentary. Examinations were performed in the 
WFSM Clinical Research Unit.
Cerebral Magnetic Resonance Imaging (MRI)
Detailed methods for MRI scans and analyses in AA-DHS MIND have been reported 
previously (29–31). As previously described, all MRI scans were obtained on a 3T MRI 
scanner (32). T1-weighted images were analyzed for structural analysis to obtain total 
intracranial volume, total gray matter and total white matter volumes using the SPM8 
segmentation procedure implemented in the VBM8 toolbox (33, 34). Brain MRI was 
performed at the first visit of the participants.
Body Weight, Blood Draw and MoCA Examinations
Body weight and fasting blood glucose were assessed at the day of visit for this study. 
Fasting measures of HbA1c were acquired at the first visit of the participants The Montreal 
Cognitive Assessment (MoCA), a screening test that assesses cognitive impairment (35), 
was administered after the participants had breakfast.
Respirometry of Blood Cells
Mitochondrial oxidative phosphorylation can be measured by evaluating the rate of oxygen 
consumption in cells and tissues of interest (36–38). Blood cell respirometry was performed 
using two complementary approaches. Intact PBMCs were assessed with a Seahorse XF24–
3 extracellular flux analyzer (Seahorse Bioscience, Billerica, MA). 250,000 PBMCs were 
loaded into each well and assessed in quadruplicate using previously described methods 
(39). Briefly, basal oxygen consumption rate (OCR) was monitored prior to chemical 
additions, followed by OCR measurements after sequential injections of oligomycin (0.75 
μM), carbonyl cyanide-4- (trifluoromethoxy) phenylhydrazone (FCCP; 1 μM), and 
antimycin A + rotenone (A/R; 1 μM each). All chemicals were obtained from SigmaAldrich. 
PBMC respiration was reported as pmol.min−1.
High-resolution respirometry of permeabilized PBMCs was performed in parallel to provide 
key measures of fatty acid oxidation and respiration driven by individual complexes. For 
these studies, 4 million PBMCs were loaded into each of 2 chambers of an Oroboros 
Oxygraph-2K (Oroboros, Innsbruck, Austria). Respirometry was performed following a 
substrate-uncoupler-inhibitor-titration reference protocol in which multiple substrates and 
inhibitors are sequentially added to measure oxygen flux due to fatty acid oxidation, 
followed by oxidative phosphorylation. PBMCs were placed into a chamber with 2 mL 
mitochondrial respiration medium, MiR05 constituting of 0.5 mM EGTA, 3 mM MgCl2, 60 
mM lactobionic acid, 20mM taurine, 10mM KH2PO4, 20mM HEPES, 110 mM D-Sucrose, 
and 1 g/L fatty acid free BSA, pH 7.1. Chambers were equilibrated at room oxygen 
concentration at 37°C for at least 30 minutes and routine endogenous respiration was 
measured, followed by addition of 7.5 mM ADP. Cells were then permeabilized with 0.04 
mg/mL digitonin, followed by addition of 0.5 mM octanoylcarnitine to evaluate fatty acid 
oxidation capacity and 0.05 mM malate to kinetically saturate the fatty acid oxidation 
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pathway. This was followed by sequential addition of 2 mM malate, 10 μM cytochrome c to 
assess outer mitochondrial membrane integrity, 5 mM pyruvate, 10 mM glutamate, 50 mM 
succinate, and 10 mM glycerophosphate. These additions target complexes I, II, and 
ubiquinone or coenzyme Q of the electron transport chain, resulting in detailed 
measurements of mitochondrial function. The electron transport chain was uncoupled with 
FCCP (by titrating 0.5 μM FCCP in each step), and then inhibited by addition of complex I 
and III inhibitors, 0.5 μM rotenone, and 2.5 μM antimycin A, measuring residual oxygen 
consumption. PBMC respiration was reported as fmol.sec−1.cell−1.
Statistical Analyses
Shapiro-Wilk tests were performed to check for normal distribution of all variables. Log 
transformations were performed for parameters with non-normal distribution. Pearson 
correlation coefficients were assessed between all variables, both raw and normalized values, 
and partial correlations adjusted for age and sex were also assessed. Significance was set at 
an α-level of 0.05. Analyses were performed using SPSS software (SPSS v22; Armonk, 
NY).
Results
Demographic and bioenergetic parameters of the human participants
Demographic parameters (age, BMI, duration of T2DM, HbAlc), bioenergetic parameters, 
and brain morphology parameters analyzed are summarized in Table 1. Representative 
bioenergetic profiles from a participant are shown in Figure 1A and 1B.
Associations between PBMC bioenergetics and brain morphology
Pearson correlation coefficients were used to compare PBMC bioenergetic parameters with 
brain morphology (Table 2). Representative scatter plots are shown in Supplemental Figures 
1A–1D. Basal, maximal FCCP-induced respiration, and ATP-linked respiration of PBMCs 
significantly positively correlated with total white matter volume (R = 0.666, 0.547, and 
0.563), while basal and maximal FCCP-induced respiration correlated significantly with 
total intracranial volume (0.588 and 0.550). Fatty acid oxidation-mediated oxygen flux 
(respiration of cells after addition of malate to kinetically saturate the fatty acid oxidation 
[FAO] pathway) significantly correlated with TWM volume and TICV (R = 0.591 and 
0.684). Similar relationships were observed between maximal electron transport (measured 
by FCCP titration) and TWM volume and TICV. Significant positive association were seen 
between FAO + complex I activity and TWM volume and TICV. Significant associations 
were observed between combined FAO + complex I + complex II activity and TWM volume 
and TICV.
As shown in Table 3, after adjusting for age and sex, basal, maximal FCCP-linked, and ATP-
linked bioenergetic capacity of PBMC remained significantly positively correlated with 
TWM volume and TICV. Spare respiratory capacity showed significant positive correlation 
with TICV in both cases, and with TGM volume when specifically controlling for sex. Fatty 
acid oxidation-mediated respiration and FAO + complex I-mediated respiration were 
significantly positively correlated with TGM volume, TWM volume, and TICV. Similar 
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significant correlations were observed between FAO + complex I + complex II and maximal 
FCCP-linked respiration and TWM volume and TICV.
As shown in Supplemental tables 1 through 4, adjustment for duration of T2DM, BMI and 
T2DM severity (HbA1c) did not affect these relationships between brain morphology and 
PBMC bioenergetic capacity.
Associations between PBMC bioenergetics and normalized brain morphology parameters
Table 4 shows the relationships between PBMC bioenergetics and brain morphologic 
parameters statistically adjusted for TICV. This adjustment caused all correlations to become 
less significant, indicating that TICV was the main driver of the associations with TWM 
volume and TGM volume.
Associations between PBMC bioenergetic capacity and MoCA test scores
Pearson and partial correlation coefficients were calculated to compare PBMC bioenergetic 
parameters with MoCA test scores before and after adjusting for age of the participants. The 
associations are summarized in Table 5. Basal respiration was significantly positively 
associated with both raw values as well as age adjusted MoCA scores; similar trends were 
observed for the other bioenergetic parameters.
Discussion
Mitochondrial bioenergetics plays a key role in the effects of aging on neuronal function 
(40). Mitochondrial dysfunction is related to numerous age-related diseases, including 
T2DM, obesity, Parkinson’s, and Alzheimer’s disease (41–44). Recent work from our 
laboratory and others indicate that measures of mitochondrial function performed in 
circulating cells can report on systemic bioenergetic capacity and are related to various age-
related conditions (45–52). The current study provides the first report that systemic 
bioenergetic capacity is related to key measures of brain morphology.
Our results indicate that systemic bioenergetic capacity, assessed by PBMC respirometry, is 
significantly positively related to total intracranial volume (TICV), a parameter estimating 
maximum pre-morbid brain volume (53). This finding suggests that differences in systemic 
bioenergetic capacity may be related to the overall development and atrophy of the brain. 
Our results also indicate that basal respiration of intact PBMCs is significantly positively 
related to cognitive function, measured using the MoCA assessment. ATP-linked respiration 
shows a strong trend while other measures in intact PBMCs are not significant. Our results 
also show that statistically adjusting for age, sex, BMI and T2DM severity (HbA1c) does not 
affect the relationships observed in this study. It is notable that while BMI and T2DM have 
been associated with alterations in mitochondrial function in previous studies, the 
relationship of systemic bioenergetic capacity with brain morphology is independent of 
these variables.
TICV is currently the most accepted and widely used measure of brain reserve and is 
associated with higher cognitive performance after adjusting for the amount of pathology in 
Alzheimer’s disease (15). Moreover, it has been previously reported that greater premorbid 
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brain volume results in better clinical and cognitive outcomes (54, 55). BMI, hyperglycemia 
and T2DM are associated with brain atrophy, cognitive impairment and dementia, with 
duration of T2DM strongly associated with brain volume loss (54). This is possibly a result 
of direct neurologic insult from altered glucose and mitochondrial metabolism, leading to 
mitochondrial dyshomeostasis and loss of synaptic integrity, affecting brain functions and 
morphology. Future studies will address whether these central metabolic alterations are 
relayed to PBMC mitochondria via non-cellular, blood-borne circulating factors that are 
potentially released from the brain, altering PBMC mitochondrial bioenergetics.
To our knowledge, the assay protocols utilized in this study are the most comprehensive 
assessment of PBMC bioenergetics to date. We examined the respiration of intact and 
permeabilized PBMCs in parallel to enable in depth analysis of electron transport chain 
activity. It should be considered that the measures presented here are interrelated and 
focused on contributors to overall mitochondrial function. For example, the individual 
activities of complexes 1 and 2, as well as fatty acid oxidation all contribute to the 
bioenergetic capacity of a cell. It should be noted that even if we were to choose p=0.01 as 
the level of significance, key relationships remain significant; particularly the relationships 
between the basal respiration and the FAO mediated respiration with TWM and TICV. 
Moreover, these relationships remain when adjusting for age, sex, duration and severity of 
T2DM, BMI and blood glucose levels.
The composition of the cohort utilized for this study is also unique and representative of a 
group that is at a greater risk of developing cognitive decline (55). Future studies should be 
designed to determine if the results can be extended to other cohorts. It is also important to 
remember that bioenergetic profiling was performed at a single time point. Therefore, 
longitudinal studies should be designed to more definitely assess the role of PBMC 
bioenergetic capacity in brain development or degeneration. Blood based bioenergetic 
profiling is rapidly emerging as a reliable measure of systemic bioenergetic capacity. To 
date, studies have focused on mixed PBMCs, as performed here, but also other cell types 
such as platelets and monocytes (52, 56–59). The design of future studies will continue to 
improve as we continue to advance our understanding of how various circulating cell types 
reflect bioenergetic changes associated with various conditions and disorders.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Clinical Perspectives
• African American individuals represent a cohort experiencing a higher risk of 
T2DM, consequently exhibiting an increased risk of cognitive decline.
• PBMC bioenergetic capacity is directly related to overall brain morphology 
and cognitive function.
• Blood-based bioenergetic profiling is a promising minimally invasive 
biomarker of systemic bioenergetic capacity.
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Figure 1: 
Representative graphs of the two different techniques used to measure PBMC respirometry. 
Bioenergetic profiles of PBMCs isolated from one participant. Respiration is measured as 
oxygen consumption rate.
Figure1A: Representative graph generated by the Seahorse XF24–3 extracellular flux 
analyzer.
Figure1B: Representative graph generated by the Oroboros O2K respirometer.
As shown in Figure 1A, injections were as follows: O=oligomycin, U=uncoupler (FCCP), 
R=rotenone, A=antimycin A. As shown in Figure 1B, multiple substrates and inhibitors 
were sequentially added to permeabilized cells and measure oxygen flux due to fatty acid 
oxidation, followed by oxidative phosphorylation. D=adenosine diphosphate, 
Dig=Digitonin, Oct=Octanoylcarnitine, M1=0.1M malate, M2=0.8M malate, c=cytochrome 
c, P=pyruvate, G=glutamate, S=succinate, Gp=glycerophosphate, U=uncoupler (FCCP), 
R=rotenone, A=antimycin A.
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Table 1:
Demographics, bioenergetics, and brain morphology parameters.
N=16 Mean SD Range
Age (years) 64.42 7.71 51.65 – 81.76
BMI (kg/m2) 34.11 7.92 25.51 – 50.64
Duration of T2D (years) 12.97 8.86 3.66 – 39.12
Fasting blood sugar (mg/dL) 150.67 52.53 79 – 283
HbAlc (%) 7.82 1.66 5.8 – 12.6
MoCA score 21.5 4.7 13.00 – 29.00
Bioenergetic Parameters
Basal (pmol.min−1) 113.13 51.15 42.05 – 169.35
Maximal uncoupled respiration (pmol.min−1) 245.53 139.12 91.30 – 657.92
Spare Respiratory Capacity (pmol.min−1) 132.40 94.20 14.30 – 412.14
ATP-linked respiration (pmol.min−1) 63.81 45.33 (−19.54) - 111.4
FAO (fmol.sec−1.cell−1) 2.66 ×10−3 1.02 ×10−3 1.19 ×10−3 - 5.35 ×10−3
FAO+ComplexI (fmol.sec−1.cell−1) 3.66 ×10−3 1.86 ×10−3 1.175 ×10−3 - 8.29 ×10−3
FAO+ComplexI+ComplexII (fmol.sec−1.cell−1) 5.05 ×10−3 2.605 ×10−3 1.475 ×10−3 - 13.09 ×10−3
Max ETS (fmol.sec−1.cell−1) 7.55 ×10−3 4.59 ×10−3 2.30 ×10−3 - 11.70 ×10−3
Brain Anatomy Parameters
Total Gray Matter Volume (GM) (cm3) 570.85 49.27 492.21 – 648.74
Total White Matter Volume (WM) (cm3) 478.73 45.21 422.24 – 553.91
Total Intracranial Volume (TICV) (cm3) 1294.10 117.59 1134.77 – 1560.82
Note: PBMC bioenergetic parameters recorded by Seahorse XF24–3 extracellular flux analyzer are reported as oxygen consumption rate (pmol.min
−1) per 250,000 cells.
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Table 2:
Relationship between PBMC respiration and brain morphology parameters measured by Pearson correlation. 
Pearson correlation coefficients and p-values for each association are shown. FAO = Fatty Acid Oxidation, 
ETS = Maximal ETC mediated respiratory system activity. Bold type = p-value ≤ 0.05. Spare respiratory 
capacity is calculated as the difference between maximal and basal Respiration.
Respirometry Parameters TGM TWM TICV
Basal Respiration R = 0.338 R = 0.666 R = 0.588
p = 0.218 p = 0.007 p = 0.021
Maximal Respiration R = 0.375 R = 0.547 R = 0.550
p = 0.169 p = 0.035 p = 0.034
Spare Respiratory Capacity R = 0.367 R = 0.408 R = 0.477
p = 0.178 p = 0.131 p = 0.072
ATP-linked Respiration R = 0.253 R = 0.563 R = 0.490
p = 0.364 p = 0.029 p = 0.064
FAO R = 0.477 R = 0.591 R = 0.684
p = 0.062 p = 0.016 p = 0.003
FAO+ComplexI R = 0.467 R = 0.519 R = 0.564
p = 0.068 p = 0.040 p = 0.023
FAO+Compl exI+ComplexII R = 0.375 R = 0.502 R = 0.528
p = 0.152 p = 0.047 p = 0.035
Max ETS R = 0.349 R = 0.503 R = 0.503
p = 0.199 p = 0.047 p = 0.047
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Table 3:
Relationship between PBMC respiration and brain morphologic parameters statistically adjusted for age and 
sex. Correlation coefficients and p-values for each association are shown. Bold type = p-value ≤ 0.05.
Adjusted for Age Adjusted for Sex
Respirometry Parameters TGM TWM TICV TGM TWM TICV
Basal Respiration R = 0.346 R = 0.668 R = 0.607 R = 0.570 R = 0.705 R = 0.709
p = 0.225 p = 0.009 p = 0.021 p = 0.033 p = 0.005 p = 0.005
Maximal Respiration R = 0.408 R = 0.566 R = 0.610 R = 0.627 R = 0.586 R = 0.676
p = 0.148 p = 0.035 p = 0.021 p = 0.016 p = 0.028 p = 0.008
Spare Respiratory Capacity R = 0.412 R = 0.430 R = 0.552 R = 0.489 R = 0.416 R = 0.525
p = 0.143 p = 0.125 p = 0.041 p = 0.076 p = 0.139 p = 0.054
ATP-linked Respiration R = 0.258 R = 0.564 R = 0.504 R = 0.532 R = 0.620 R = 0.644
p = 0.372 p = 0.036 p = 0.066 p = 0.050 p = 0.018 p = 0.013
FAO R = 0.474 R = 0.589 R = 0.683 R = 0.460 R = 0.603 R = 0.674
p = 0.074 p = 0.021 p = 0.005 p = 0.084 p = 0.017 p = 0.006
FAO+ComplexI R = 0.483 R = 0.529 R = 0.594 R = 0.436 R = 0.534 R = 0.547
p = 0.068 p = 0.043 p = 0.020 p = 0.105 p = 0.040 p = 0.035
FAO+ComplexI+ComplexII R = 0.411 R = 0.531 R = 0.593 R = 0.443 R = 0.502 R = 0.548
p = 0.128 p = 0.042 p = 0.020 p = 0.099 p = 0.057 p = 0.034
Max ETS R = 0.379 R = 0.527 R = 0.556 R = 0.393 R = 0.503 R = 0.513
p = 0.164 p = 0.044 p = 0.031 p = 0.147 p = 0.056 p = 0.050
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Table 4:
Relationships between PBMC respiration and brain morphologic parameters statistically adjusted for TICV 
measured by Partial correlation. Correlation coefficients and p-values for each association are shown.
Adjusted for TICV
Respirometry Parameters TGM TWM
Basal Respiration R = −0.105 R = 0.510
p = 0.734 p = 0.062
Maximal Respiration R = 0.051 R = 0.313
p = 0.870 p = 0.277
Spare Respiratory Capacity R = 0.165 R = 0.143
p = 0.589 p = 0.627
ATP-linked Respiration R = −0.144 R = 0.445
p = 0.638 p = 0.110
FAO R = 0.089 R = 0.251
p = 0.761 p = 0.366
FAO+ComplexI R = 0.166 R = 0.282
p = 0.571 p = 0.308
FAO+ComplexI+ComplexII R = −0.003 R = 0.322
p = 0.991 p = 0.242
Max ETS R = 0.030 R = 0.386
p = 0.918 p = 0.156
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Table 5:
Relationship between PBMC respiration and MoCA scores (raw values and values adjusted for age) measured 
by Pearson correlation (raw values) (first panel) and partial correlation (adjusted for age) (second panel). 
Pearson correlation coefficients and p-values for each association are shown. Bold type = p-value ≤ 0.05.
Raw values Adjusted for age
Respirometry Parameters MoCA MoCA
Basal Respiration R = 0.571 R = 0.579
p = 0.026 p = 0.030
Maximal Respiration R = 0.301 R = 0.328
p = 0.276 p = 0.252
Spare Respiratory Capacity R = −0.067 R = −0.050
p = 0.812 p = 0.866
ATP-linked Respiration R = 0.479 R = 0.484
p = 0.071 p = 0.079
FAO R = 0.196 R = 0.191
p = 0.468 p = 0.495
FAO+ComplexI R = −0.002 R = 0.006
p = 0.995 p = 0.982
FAO+Compl exI+ComplexII R = 0.131 R = 0.153
p = 0.630 p = 0.586
Max ETS R = 0.155 R = 0.175
p = 0.566 p = 0.534
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